Francisco Hermida-Prado

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Cancers

Journal of clinical medicine

Cancer research

Biomedicines

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Aug 6o 2018

United States

Research Fellow :: Medical Oncology

Publications

Francisco Hermida-Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi, Zhengtao Chu, Avery Feit, Marco Campisi, Minyue Chen, Agostina Nardone, Cristina Guarducci, Klothilda Lim, Alba Font-Tello, Irene Lee, Juana María García-Pedrero, Israel Cañadas, Judith Agudo, Ying Huang, Tal Sella, Qingchun Jin, Nabihah Tayob, Elizabeth A Mittendorf, Sara M Tolaney, Xintao Qiu, Henry W Long, William Fraser Symmans, Jia-Ren Lin, Sandro Santagata, Isabelle Bedrosian, Denise A Yardley, Ingrid A Mayer, Edward T Richardson, Giacomo Oliveira, Catherine J Wu, Eugene F Schuster, Mitchell Dowsett, Alana L Welm, David A Barbie, Otto Metzger Filho, Rinath M Jeselsohn
Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer. Cancer research (2023)
Agostina Nardone, Xintao Qiu, Sándor Spisák, Zsuzsanna Nagy, Ariel Feiglin, Avery Feit, Gabriella Cohen, Yingtian Xie, Alba Font-Tello, Cristina Guarducci, Francisco Hermida-Prado, Sudeepa Syamala, Klothilda Lim, Miguel Munoz Gomez, Matthew Pun, MacIntosh Grant Cornwell, Weihan Liu, Aysegul Ors, Hisham Mohammed, Paloma Cejas, Jane B Brock, Matthew L Freedman, Eric P Winer, Xiaoyong Fu, Rachel Schiff, Henry W Long, Otto Metzger Filho, Rinath M Jeselsohn
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer. Cancer research 82 (20) (2022)
Daniel Pedregal-Mallo, Francisco Hermida-Prado, Rocío Granda-Díaz, Irene Montoro-Jiménez, Eva Allonca, Esperanza Pozo-Agundo, Mónica Álvarez-Fernández, César Álvarez-Marcos, Juan Pablo Rodrigo, Juana María García-Pedrero
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas. Cancers 12 (7) (2020)
Mario Sanchez-Canteli, Francisco Hermida-Prado, Christian Sordo-Bahamonde, Irene Montoro-Jiménez, Esperanza Pozo-Agundo, Eva Allonca, Aitana Vallina-Álvarez, César Álvarez-Marcos, Segundo González, Juana María García-Pedrero, Juan Pablo Rodrigo
Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma. Biomedicines 8 (12) (2020)
Juan Carlos De Vicente, Paula Donate-Pérez Del Molino, Juan Pablo Rodrigo, Eva Allonca, Francisco Hermida-Prado, Rocío Granda-Díaz, Tania Rodríguez Santamarta, Juana María García-Pedrero
SOX2 Expression Is an Independent Predictor of Oral Cancer Progression. Journal of clinical medicine 8 (10) (2019)
Javier Menéndez-Menéndez, Francisco Hermida-Prado, Rocío Granda-Díaz, Alicia González, Juana María García-Pedrero, Nagore Del-Río-Ibisate, Alicia González-González, Samuel Cos, Carolina Alonso-González, Carlos Martínez-Campa
Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin. Cancers 11 (7) (2019)
Francisco Hermida-Prado, Rocío Granda-Díaz, Nagore Del-Río-Ibisate, M Ángeles Villaronga, Eva Allonca, Irati Garmendia, Luis M Montuenga, Rene Rodriguez, Aitana Vallina, César Alvarez-Marcos, Juan Pablo Rodrigo, Juana María García-Pedrero
The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Cancers 11 (11) (2019)
Rocío Granda-Díaz, Sofía T Menéndez, Daniel Pedregal-Mallo, Francisco Hermida-Prado, Rene Rodriguez, Laura Suárez-Fernández, Aitana Vallina, Mario Sánchez-Canteli, Aida Rodríguez, M Soledad Fernández-García, Juana María García-Pedrero, Juan Pablo Rodrigo
The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions. Cancers 11 (3) (2019)
Francisco Hermida-Prado, M Ángeles Villaronga, Rocío Granda-Díaz, Nagore Del-Río-Ibisate, Laura Santos, Maria Ana Hermosilla, Patricia Oro, Eva Allonca, Jackeline Agorreta, Irati Garmendia, Juan Tornín, Jhudit Perez-Escuredo, Rocío Fuente, Luis M Montuenga, Francisco Morís, Juan Pablo Rodrigo, Rene Rodriguez, Juana María García-Pedrero
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. Journal of clinical medicine 8 (8) (2019)
Saúl Álvarez-Teijeiro, Cristina García-Inclán, M Ángeles Villaronga, Pedro Casado, Francisco Hermida-Prado, Rocío Granda-Díaz, Juan Pablo Rodrigo, Fernando Calvo, Nagore Del-Río-Ibisate, Alberto Gandarillas, Francisco Morís, Mario Hermsen, Pedro Cutillas, Juana María García-Pedrero
Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets. Cancers 10 (9) (2018)

Francisco Hermida-Prado.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco Hermida-Prado